Clinical evaluation of Mashiningan and Daiokanzoto for the relief of constipation in Parkinson's disease
- Conditions
- Constipation of Parkinson's disease patients
- Registration Number
- JPRN-UMIN000013879
- Lead Sponsor
- Division of Oriental Medicine Center for Community Medicine Jichi Medical University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 50
Not provided
1) Pregnant women or nursing mothers 2) Patients with apparent obstructions (such as tumors or hernias) in the intestinal tract 3) Patients with drug-induced constipation 4) Patients with known megacolon/megarectum or intestinal pseudo-obstruction 5) Patients who have undergone prior gastrointestinal surgery or abdominal surgery during the 3 months prior to the start of the study 6) Patients with significant cardiac, hepatic, pulmonary, renal, or mental diseases 7) Patients with severe clinical findings or abnormal laboratory (hematology/urinalysis) findings 8) Patients with uncontrolled hypertension, hyperaldosteronism, hypokalemia, or myopathy 9) Patients who may not comply with this research study protocol 10) Patients diagnosed with cancer within 5 years from the start of the study (except for carcinoma in situ) 11) Patients with constipation that is controlled through treatment with Mashiningan or Daiokanzoto prior to the start of this study
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Constipation assessment scale
- Secondary Outcome Measures
Name Time Method 1) Bristol stool scale 2) Presence or absence of adverse effects 3) Other individual outcomes, obtained from responses to the questionnaire(Abdominal bloating, stool frequency, sensation of incomplete evacuation, straining, etc.)
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.